New York and Copenhagen–based start-up HERVolution Therapeutics has raised $11.7 million in series A financing. The company ...

Key findings from 2024 focused on conditions like vaccine-induced immune thrombotic thrombocytopenia, immune thrombocytopenia ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

Since the COVID-19 pandemic, considerable advances have been made to improve epidemic preparedness by accelerating ...

This study reveals how SARS-CoV-2 infection significantly alters human milk composition, while COVID-19 vaccination causes ...

However, the vaccine and its manufacturers received criticism because it was less effective than the mRNA Covid vaccines ...

A woman from Scotland has become the first patient in Europe to receive a cancer jab for gastro-oesophageal cancer. Jennifer ...

Vaccination against COVID-19 reduces the incidence of hospitalization or death and the development of severe disease among those with a breakthrough infection.

Current National Institutes of Health (NIH) policy allows corporations to commercialize medical technologies with few ...

The Russian Ministry of Health — as reported by the state-owned news agency TASS — has declared that a cancer vaccine will be ...